demonstrated that CAR T-cells equipped with a fully human single-chain variable fragment (scFv) targeting TROP2 effectively killed TROP2-positive pancreatic cancer cells and inhibited tumor growth in xenograft models. The gene discussed is TACSTD2; the disease is familial pancreatic carcinoma.